(National Foundation for Cancer Research) A translational research project supported by the National Foundation for Cancer Research (NFCR) has been awarded $700,000 from Virginia Catalyst to advance its lead cancer drug candidate. NFCR’s $400,000 translational research support for the project in 2017 and 2018 is in addition to over $850,000 in basic cancer research funding which the organization has provided to Dr. Fisher and his lab since 2008.

Original source: https://www.eurekalert.org/pub_releases/2019-12/nffc-nft122319.php